TB500 17-23 FRAG 10 mg

Description

What it is

TB-500 Fragment (17–23), also called fequesetide or LKKTETQ, is a short peptide derived from the core active sequence of thymosin beta-4. This fragment retains the actin-binding capability of the parent molecule, making it a valuable tool for cellular and tissue-level research.

In laboratory studies, TB-500 Fragment (17–23) is commonly used to investigate:

• Actin-mediated cell migration

• Cytoskeletal organization

• Immune-response modulation

• Tissue-response and remodeling pathways

• Angiogenesis modeling

• Inflammation frameworks

• Musculoskeletal research models

Its compact structure and targeted actin affinity provide a focused platform for exploring how small peptides influence cellular behavior and repair-related biochemical signaling.

ChainX Peptides provides TB-500 Fragment (17–23) in high-purity form for controlled research use only.

For laboratory research use only. Not for human consumption.

Why people are interested

• premium research‑grade material
• popular in advanced lab settings
• lot‑specific COA support

How it works (research)

Studied in laboratory settings for effects on key cellular pathways.

What you get

• High‑purity material (≥98% HPLC), lot‑specific COA available
• Careful handling and cold‑chain fulfillment
• Secure packaging for lab workflows

Good to know

Best outcomes are associated with consistent routines around sleep, nutrition, and training.

Important: ChainX sells research products. Not for human consumption or veterinary use. For laboratory research by qualified professionals only.

No medical claims. Not intended to diagnose, treat, cure, or prevent any disease.